BioCentury-BayHelix East-West Summit 2022
Event Date: 14th November 2022 to 26th November 2022
Event Location: Redwood City, CA
Meet with usJoin CEO Dr. Lingshi Tan where he will provide insights as a panelist for “What’s Next on the Bridge to Innovation?” on Wednesday, Nov. 16, 2:15 pm. This session will explore how mobile Chinese entrepreneurs and investors will contribute to global innovation.
For almost a decade, BioCentury and BayHelix and our partners have brought together a global community of C-suite executives and investors focused on biopharma innovation and cross-border collaboration. But the world has changed: Emerging biopharmas in the U.S., Europe and Asia now face the same dilemma: How do you globalize to deliver innovation to patients and achieve an ROI for investors?
- A handful of biopharma companies will build global operations.
- Most will achieve global economics through partnering and licensing.
- Others will capture a share of the economics by enabling global development and financing.
- And all will require trusted cross-border relationships for success.
Globalizing drug development is imperative for creating medicines that reach all patients, regardless of where they live. That takes investors and company leaders with global vision and strategy, in a rapidly evolving environment.